Saikosaponins: a potential treatment option for systemic lupus erythematosus.
about
Saikosaponin A, an active glycoside from Radix bupleuri, reverses P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cells and HepG2/ADM cells.Saikosaponin-d Enhances the Anticancer Potency of TNF-α via Overcoming Its Undesirable Response of Activating NF-Kappa B Signalling in Cancer Cells.Anti-Inflammation Effects and Potential Mechanism of Saikosaponins by Regulating Nicotinate and Nicotinamide Metabolism and Arachidonic Acid Metabolism.Saikosaponin A mediates the inflammatory response by inhibiting the MAPK and NF-κB pathways in LPS-stimulated RAW 264.7 cells.The Role of Saikosaponins in Therapeutic Strategies for Age-Related Diseases.
P2860
Saikosaponins: a potential treatment option for systemic lupus erythematosus.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Saikosaponins: a potential treatment option for systemic lupus erythematosus.
@en
Saikosaponins: a potential treatment option for systemic lupus erythematosus.
@nl
type
label
Saikosaponins: a potential treatment option for systemic lupus erythematosus.
@en
Saikosaponins: a potential treatment option for systemic lupus erythematosus.
@nl
prefLabel
Saikosaponins: a potential treatment option for systemic lupus erythematosus.
@en
Saikosaponins: a potential treatment option for systemic lupus erythematosus.
@nl
P2093
P2860
P1476
Saikosaponins: a potential treatment option for systemic lupus erythematosus
@en
P2093
P2860
P2888
P304
P356
10.1007/S11845-010-0646-4
P577
2010-11-26T00:00:00Z